ArticleSurgery today2025
How antithrombotic therapy influences the clinical outcomes of emergency laparoscopic cholecystectomy for acute cholecystitis.
Article in Surgery today, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo investigate the impact of antithrombotic therapy on the clinical outcomes of emergency laparoscopic cholecystectomy for acute cholecystitis.
methodsA single-center retrospective surgical database included 550 patients who underwent emergency cholecystectomy between 2005 and 2025, and the current study population included 329 patients who underwent emergency laparoscopic cholecystectomy, excluding open cholecystectomy and chronic cholecystitis. Patients were divided into two groups: patients receiving antithrombotic therapy (ATT, n = 143) and those not receiving antithrombotic therapy (non-ATT, n = 186). The ATT group was divided into aspirin monotherapy (aspirin, n = 62) and multiple antithrombotic therapy (mATT, n = 21) groups. Outcome variables were compared between the groups, and risk factors for intraoperative blood loss were assessed using logistic multivariate analysis.
resultsThe overall rate of severe postoperative complications was 2.7% and the surgical mortality was zero in the entire cohort. Intraoperative blood loss was significantly larger in the ATT group. A multivariate analysis showed that dialysis (odds ratio: 5.210, P = 0.019) and severe acute cholecystitis (odds ratio: 2.630, P < 0.001) were significant risk factors for increased intraoperative blood loss. There were no significant differences in the perioperative outcomes between the aspirin and mATT groups.
conclusionAlthough dialysis and severe acute cholecystitis contribute to increased intraoperative blood loss, emergency laparoscopic cholecystectomy may be performed safely, even in patients receiving multiple antithrombotic therapies.
Indexed as
Identifiers
40586845What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.